Kamilia Smith, MD, FACOG, NCMP, explores the comprehensive management of menopausal vasomotor symptoms (VMS), addressing diagnostic challenges, treatment barriers, patient education, emerging therapies, sleep impacts, and culturally sensitive care approaches, while emphasizing the importance of shared decision-making and long-term health implications.
EP. 1: Important Clinical Considerations for Patients Experiencing Vasomotor Symptoms (VMS)
December 17th 2024Kamilia Smith, MD, FACOG, NCMP, discusses how identifying and effectively treating vasomotor symptoms (VMS) in menopausal women are hindered by diagnostic challenges, inadequate screening practices, and patient barriers including stigma, lack of awareness, and concerns about treatment options.
Watch
EP. 2: Evaluating Patient Attitudes Toward Conventional VMS Therapies
December 24th 2024Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with widespread misinformation about treatment options, create significant barriers that discourage women from seeking appropriate medical care for menopausal symptoms.
Watch
EP. 3: Patient Education About VMS and Associated Therapies
December 31st 2024Kamilia Smith, MD, FACOG, NCMP, discusses how educating patients about the serious long-term health risks of untreated vasomotor symptoms (VMS) requires a comprehensive strategy that includes clear communication about cardiovascular and cognitive consequences, alongside practical steps to improve treatment adoption and adherence.
Watch
EP. 4: Shared Decision-Making with Neurokinin-Targeted Therapies for VMS
January 7th 2025Kamilia Smith, MD, FACOG, NCMP, discusses how shared decision-making approaches combined with emerging neurokinin-targeted therapies offer promising solutions to improve treatment adherence and overcome historical barriers in managing vasomotor symptoms (VMS).
Watch